These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35593362)

  • 21. Liposomes: An Emerging Approach for the Treatment of Cancer.
    Mishra K; Jain AK
    Curr Pharm Des; 2021; 27(20):2398-2414. PubMed ID: 33823772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
    Fathi S; Oyelere AK
    Future Med Chem; 2016 Nov; 8(17):2091-2112. PubMed ID: 27774793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy.
    Mukherjee A; Bisht B; Dutta S; Paul MK
    Acta Pharmacol Sin; 2022 Nov; 43(11):2759-2776. PubMed ID: 35379933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
    Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
    J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
    Immordino ML; Dosio F; Cattel L
    Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends and developments in liposome drug delivery systems.
    Lian T; Ho RJ
    J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal Delivery Systems: Design Optimization and Current Applications.
    Abu Lila AS; Ishida T
    Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation.
    Bayat F; Hosseinpour-Moghadam R; Mehryab F; Fatahi Y; Shakeri N; Dinarvand R; Ten Hagen TLM; Haeri A
    Adv Colloid Interface Sci; 2020 Mar; 277():102121. PubMed ID: 32092487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted liposomal drug delivery in cancer.
    Medina OP; Zhu Y; Kairemo K
    Curr Pharm Des; 2004; 10(24):2981-9. PubMed ID: 15379663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in liposome formulations for breast cancer therapeutics.
    Yang B; Song BP; Shankar S; Guller A; Deng W
    Cell Mol Life Sci; 2021 Jul; 78(13):5225-5243. PubMed ID: 33974093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-targeted liposomes for cancer treatment.
    Sapra P; Tyagi P; Allen TM
    Curr Drug Deliv; 2005 Oct; 2(4):369-81. PubMed ID: 16305440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-targeted liposome design: challenges and fundamental considerations.
    Noble GT; Stefanick JF; Ashley JD; Kiziltepe T; Bilgicer B
    Trends Biotechnol; 2014 Jan; 32(1):32-45. PubMed ID: 24210498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.
    Mamasheva E; O'Donnell C; Bandekar A; Sofou S
    Mol Pharm; 2011 Dec; 8(6):2224-32. PubMed ID: 21899300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in Tumor Targeted Liposomes.
    Jain A; Jain
    Curr Mol Med; 2018; 18(1):44-57. PubMed ID: 29663884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advancements in Liposome-Based Strategies for Effective Drug Delivery to the Brain.
    Zamani P; Penson PE; Barreto GE; Sahebkar A
    Curr Med Chem; 2021; 28(21):4152-4171. PubMed ID: 33342401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona.
    Caracciolo G
    Nanoscale; 2018 Mar; 10(9):4167-4172. PubMed ID: 29450412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding and interstitial penetration of liposomes within avascular tumor spheroids.
    Kostarelos K; Emfietzoglou D; Papakostas A; Yang WH; Ballangrud A; Sgouros G
    Int J Cancer; 2004 Nov; 112(4):713-21. PubMed ID: 15382056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomes for Tumor Targeted Therapy: A Review.
    Wang S; Chen Y; Guo J; Huang Q
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimuli-responsive Smart Liposomes in Cancer Targeting.
    Jain A; Jain SK
    Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.